东阳光药(06887)有意回购公司股份

Core Viewpoint - Dongyang Sunshine Pharmaceutical (06887) intends to repurchase its own shares in the open market, reflecting the management's confidence in the company's long-term business prospects and development [1] Group 1 - The management team believes that the share repurchase proposal is in the best interest of both the company and its shareholders [1]